Published online before print May 10, 2001, doi: 10.1161/hh1001.091521
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2001 American Heart Association, Inc.
Integrative Physiology |
Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1–Deficient Mice
From the Program of Developmental Cardiovascular Biology (P.W., A.P.P., I.M.C., Z.Y.W., A.P., K.M., N.D., M.D.L., S.-F. Y., M.-E. L., M.A.P.), the Cardiovascular (S.F.-Y., M.-E.L.) and Pulmonary and Critical Care Divisions (M.D.L., M.A.P.), and the Department of Pathology (H.G.R.), Brigham and Women’s Hospital, Boston, Mass; the Department of Medicine (A.P., M.D.L., S.-F.Y., M.-E.L., M.A.P.), Harvard Medical School, Boston, Mass.
Correspondence to Mark A. Perrella, Pulmonary and Critical Care Division, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115. E-mail mperrella{at}rics.bwh.harvard.edu
Abstract—Heme oxygenase (HO) is a cytoprotective enzyme that degrades heme (a potent oxidant) to generate carbon monoxide (a vasodilatory gas that has anti-inflammatory properties), bilirubin (an antioxidant derived from biliverdin), and iron (sequestered by ferritin). Because of properties of HO and its products, we hypothesized that HO would be important for the regulation of blood pressure and ischemic injury. We studied chronic renovascular hypertension in mice deficient in the inducible isoform of HO (HO-1) using a one kidney–one clip (1K1C) model of disease. Systolic blood pressure was not different between wild-type (HO-1+/+), heterozygous (HO-1+/-), and homozygous null (HO-1-/-) mice at baseline. After 1K1C surgery, HO-1+/+ mice developed hypertension (140±2 mm Hg) and cardiac hypertrophy (cardiac weight index of 5.0±0.2 mg/g) compared with sham-operated HO-1+/+ mice (108±5 mm Hg and 4.1±0.1 mg/g, respectively). However, 1K1C produced more severe hypertension (164±2 mm Hg) and cardiac hypertrophy (6.9±0.6 mg/g) in HO-1-/- mice. HO-1-/- mice also experienced a high rate of death (56%) within 72 hours after 1K1C surgery compared with HO-1+/+ (25%) and HO-1+/- (28%) mice. Assessment of renal function showed a significantly higher plasma creatinine in HO-1-/- mice compared with HO-1+/- mice. Histological analysis of kidneys from 1K1C HO-1-/- mice revealed extensive ischemic injury at the corticomedullary junction, whereas kidneys from sham HO-1-/- and 1K1C HO-1+/- mice appeared normal. Taken together, these data suggest that chronic deficiency of HO-1 does not alter basal blood pressure; however, in the 1K1C model an absence of HO-1 leads to more severe renovascular hypertension and cardiac hypertrophy. Moreover, renal artery clipping leads to an acute increase in ischemic damage and death in the absence of HO-1.
Key Words: hypertension • ischemia • oxidative injury • endothelin
This article has been cited by other articles:
 |
|
 |
|
  J. Li, T. Ichikawa, L. Villacorta, J. S. Janicki, G. L. Brower, M. Yamamoto, and T. Cui Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1843 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Li, Y. Guo, Q. Ou, C. Cui, W.-J. Wu, W. Tan, X. Zhu, L. B. Lanceta, S. K. Sanganalmath, B. Dawn, et al. Gene Transfer of Inducible Nitric Oxide Synthase Affords Cardioprotection by Upregulating Heme Oxygenase-1 Via a Nuclear Factor-{kappa}B-Dependent Pathway Circulation, September 29, 2009; 120(13): 1222 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Vera, S. Kelsen, and D. E. Stec Kidney-Specific Induction of Heme Oxygenase-1 Prevents Angiotensin II Hypertension Hypertension, October 1, 2008; 52(4): 660 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Scragg, M. L. Dallas, J. A. Wilkinson, G. Varadi, and C. Peers Carbon Monoxide Inhibits L-type Ca2+ Channels via Redox Modulation of Key Cysteine Residues by Mitochondrial Reactive Oxygen Species J. Biol. Chem., September 5, 2008; 283(36): 24412 - 24419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mito, R. Ozono, T. Oshima, Y. Yano, Y. Watari, Y. Yamamoto, A. Brydun, K. Igarashi, and M. Yoshizumi Myocardial Protection Against Pressure Overload in Mice Lacking Bach1, a Transcriptional Repressor of Heme Oxygenase-1 Hypertension, June 1, 2008; 51(6): 1570 - 1577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Abraham and A. Kappas Pharmacological and Clinical Aspects of Heme Oxygenase Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Nath, L. V. d'Uscio, J. P. Juncos, A. J. Croatt, M. C. Manriquez, S. T. Pittock, and Z. S. Katusic An analysis of the DOCA-salt model of hypertension in HO-1-/- mice and the Gunn rat Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H333 - H342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kirkby, C. Baylis, A. Agarwal, B. Croker, L. Archer, and C. Adin Intravenous bilirubin provides incomplete protection against renal ischemia-reperfusion injury in vivo Am J Physiol Renal Physiol, February 1, 2007; 292(2): F888 - F894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Olszanecki, R. Rezzani, S. Omura, D. E. Stec, L. Rodella, F. T. Botros, A. I. Goodman, G. Drummond, and N. G. Abraham Genetic suppression of HO-1 exacerbates renal damage: reversed by an increase in the antiapoptotic signaling pathway Am J Physiol Renal Physiol, January 1, 2007; 292(1): F148 - F157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. T. Botros and L. G. Navar Interaction between endogenously produced carbon monoxide and nitric oxide in regulation of renal afferent arterioles Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2772 - H2778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Bernhardt, V. Campean, S. Kany, J.-S. Jurgensen, A. Weidemann, C. Warnecke, M. Arend, S. Klaus, V. Gunzler, K. Amann, et al. Preconditional Activation of Hypoxia-Inducible Factors Ameliorates Ischemic Acute Renal Failure J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1970 - 1978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Kirkby and C. A. Adin Products of heme oxygenase and their potential therapeutic applications Am J Physiol Renal Physiol, March 1, 2006; 290(3): F563 - F571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wu and R. Wang Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Adin, B. P. Croker, and A. Agarwal Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney Am J Physiol Renal Physiol, April 1, 2005; 288(4): F778 - F784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Li, H. Jiang, L. Yang, S. Quan, S. Dinocca, F. Rodriguez, N. G. Abraham, and A. Nasjletti Angiotensin II induces carbon monoxide production in the perfused kidney: relationship to protein kinase C activation Am J Physiol Renal Physiol, November 1, 2004; 287(5): F914 - F920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Sikorski, T. Hock, N. Hill-Kapturczak, and A. Agarwal The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury Am J Physiol Renal Physiol, March 1, 2004; 286(3): F425 - F441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Rodriguez, B. D. Lamon, W. Gong, R. Kemp, and A. Nasjletti Nitric Oxide Synthesis Inhibition Promotes Renal Production of Carbon Monoxide Hypertension, February 1, 2004; 43(2): 347 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Vicente, M. I. Guillen, A. Habib, and M. J. Alcaraz Beneficial Effects of Heme Oxygenase-1 Up-Regulation in the Development of Experimental Inflammation Induced by Zymosan J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1030 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Chen, S.-F. Yet, and M. A. Perrella Role of Heme Oxygenase-1 in the Regulation of Blood Pressure and Cardiac Function Experimental Biology and Medicine, May 1, 2003; 228(5): 447 - 453. [Abstract] [Full Text] [PDF]
|
|